Evidence map›Paper›PMID 41158046›Full record

ArticleZhongguo fei ai za zhi = Chinese journal of lung cancer2025

[Cytomegalovirus Gastritis Induced by Immune Checkpoint Inhibitors Treatment 
in Lung Adenocarcinoma: A Case Report].

Xiaoyan Si, Bei Tan, Xin Cheng, Mengzhao Wang, Xiaotong Zhang, Li Zhang

Abstract readCase ReportsEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiaoyan SiDepartment of Pulmonary and Critical Care Medicine, 
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 
Beijing 100730, China.
Bei TanDepartment of Gastroenterology, 
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 
Beijing 100730, China.
Xin ChengDepartment of Nuclear Medicine, 
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 
Beijing 100730, China.
Mengzhao WangDepartment of Pulmonary and Critical Care Medicine, 
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 
Beijing 100730, China.
Xiaotong ZhangDepartment of Pulmonary and Critical Care Medicine, 
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 
Beijing 100730, China.
Li ZhangDepartment of Pulmonary and Critical Care Medicine, 
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 
Beijing 100730, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immune checkpoint inhibitors (ICIs) have been approved for the treatment of a variety of solid tumors and hematological malignancies. Adverse reactions caused by ICIs have been gradually focused on. Cytomegalovirus (CMV) gastritis after ICIs treatment is relatively rare. Here we reported a case of advanced lung adenocarcinoma who experienced recurrent upper abdominal pain and vomiting after Pembrolizumab treatment. CMV gastritis was diagnosed through gastroscopy. The patient's symptoms improved after antiviral treatment. During the treatment of ICIs, attention should be paid to the differential diagnosis of upper abdominal pain symptoms, and vigilance should be maintained against CMV gastritis. It is difficult to differentiate CMV gastritis and immune-related gastritis judging from symptoms, and gastroscopy is important for differential diagnosis.
.

Indexed as

Adenocarcinoma of LungCytomegalovirusCytomegalovirus InfectionsGastritisImmune Checkpoint InhibitorsLung NeoplasmsHumansImmune Checkpoint InhibitorsCase reportCytomegalovirus gastritisImmune checkpoint inhibitorsLung neoplasms

Identifiers

PMID41158046
PMCPMC12580386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.